Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< RESEARCH IN PSYCHIATRY

October 2022

PSYCHIATRY

IMPROVING THE CARE OF OPIOID USE DISORDER AND PAIN

Featuring: Sara Becker, PhD, C Hendricks Brown, PhD

Two Northwestern and IPHAM-affiliated researchers, Sara Becker, PhD, the Alice Hamilton Professor of Psychiatry and director of IPHAM’s Center for Dissemination and Implementation Science, and C Hendricks Brown, PhD, professor of Psychiatry and Behavioral Sciences and Medical Social Sciences, are multiple principal investigators on a $15.8 million center grant funded by the National Institute on Drug Abuse (NIDA).

The grant supports a “Research Adoption Support Center,” a center that provides coordination and implementation support to a network of newly funded HEAL Data2Action Innovation Projects. The Data2Action Projects are tasked with rapidly using real-world data to improve the care of opioid use disorder (OUD) and pain. The contact principal investigator is Mark P McGovern, PhD, from Stanford University. Multiple Principal Investigators include Becker and Brown of Northwestern and Will Becker, PhD, of Yale University.

Northwestern’s role is to direct two of the major scientific cores. Brown will lead the Research and Evaluation Core, which will provide implementation science expertise to the projects and conduct a formative evaluation of the Data2Action network. Becker will lead the Substance Use Disorder Implementation Support Core, which will help projects to select, implement, and sustain evidence-based practices to address specific service delivery gaps related to OUD.

Becker and Brown are also each directors of major research components of a recently awarded $10 million Clinical Research Center Grant (P50) focused on dissemination and implementation of effective addiction services funded by NIDA, so there will be multiple opportunities for synergy and cross-fertilization across these major projects.

“I am thrilled to be able to partner with Hendricks to lead this center as part of the landmark HEAL Data2Action Initiative. The combination of this new U2C center and our new P50 presents an unparalleled opportunity to advance the dissemination and implementation of effective addiction health services,” said Becker.


“The number of people dying from overdose in the US has exceeded 100,000 this last year, more than a 25% rise from the year before. There has been a growing recognition that these unacceptably high rates are due not from a lack of effective prevention or treatments, but rather from absent or inadequate delivery systems,” said Brown. “By bringing in modern implementation science approaches to the field of addiction and partnering with local decision makers, we intend to reduce these deaths in specific communities and point the ways that other communities can follow.”

​Other Northwestern researchers involved in the project include Carlos Gallo, PhD, Kelli Scott, PhD, Wouter Vermeer, PhD, and Uri Wilensky, PhD.

This article was originally published in the Northwestern University Feinberg School of Medicine on October17, 2022.
Sara Becker, PhD headshot
Sara Becker, PhD, Director, IPHAM Center for Dissemination and Implementation Science
Alice Hamilton Professor of Psychiatry
Professor of Psychiatry and Behavioral Sciences and Medical Social Sciences
Northwestern University Feinberg School of Medicine
C Hendricks Brown, PhD headshot
C Hendricks Brown, PhD, Professor of Psychiatry and Behavioral Sciences and Medical Social Sciences
Northwestern University Feinberg School of Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​
Call 844.344.6663
Find an NM Psychiatrist

You May Also Like

View through microscope

January 2021

PSYCHIATRY
Protein Regulation Network May Influence Psychiatric Disorders
Michael Brook, PhD headshot

December 2020

PSYCHIATRY
Championing Research at the Intersection of Behavioral Science and the Law
Hippocampus x-ray

November 2020

PSYCHIATRY
Cilia Defects Linked to Schizophrenia

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties